Neurocrine Biosciences: Fear Not The IRA (NASDAQ:NBIX)
designer491 Shares of Neurocrine Biosciences (NASDAQ:NBIX) have been stuck in a range recently due to a combination of a lack of appreciation for good news on the clinical side with two phase 3 trial wins for crinecerfont and the continued strong growth of Ingrezza, and some market “appreciation” on the downside due to the two…